Top Markets
Coin of the day
LabTurbo Biotech Corporation LabTurbo Biotech Corporation

LabTurbo Biotech Corporation

7725
Rank in Stocks #27079
Labturbo Biotech Corporation specializes in pioneering technological... Labturbo Biotech Corporation specializes in pioneering technological advancements. The company provides a range of sophisticated solutions for laboratory automation and molecular biology, which include their AIO SP-qPCR Automation System, Liquid Handling PCR Setup System, and DNA/RNA Extractor Compact Systems. Founded on June 12, 2019, its main operations are based in Taipei, Taiwan.
Share Price
$0.7361475
Market Cap
$35.29M
Change (1 day)
0.00%
Change (1 year)
-11.50%
Country
TW
Trade LabTurbo Biotech Corporation (7725)

Category

P/E ratio for LabTurbo Biotech Corporation (7725)
P/E ratio as of 2026 TTM: 0
According to LabTurbo Biotech Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for LabTurbo Biotech Corporation from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
29.20 -
US
30.62 -
NL
32.46 -
AU
-7.93 -
US
- -
CH
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.